Xiaomei Sui

562 total citations
21 papers, 449 citations indexed

About

Xiaomei Sui is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaomei Sui has authored 21 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Xiaomei Sui's work include Hedgehog Signaling Pathway Studies (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Xiaomei Sui is often cited by papers focused on Hedgehog Signaling Pathway Studies (3 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Xiaomei Sui collaborates with scholars based in China, United States and Netherlands. Xiaomei Sui's co-authors include John Lahad, Madhuri Kango‐Singh, E. Neely Atkinson, Wen-Lin Kuo, Carla L. Warneke, Joe W. Gray, Karen H. Lu, Kwai Wa Cheng, Jinsong Liu and Georg Halder and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Oncogene.

In The Last Decade

Xiaomei Sui

19 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaomei Sui China	11	330	112	110	82	46	21	449
Jason P. Frazier United States	7	397 1.2×	94 0.8×	160 1.5×	42 0.5×	47 1.0×	12	500
Michaela Bissinger Germany	11	387 1.2×	172 1.5×	101 0.9×	129 1.6×	23 0.5×	16	549
Tai-On Yau Hong Kong	6	436 1.3×	155 1.4×	133 1.2×	114 1.4×	27 0.6×	6	565
Maria Teresa Vento Italy	8	274 0.8×	105 0.9×	153 1.4×	87 1.1×	26 0.6×	9	406
Laura Rodón United States	6	447 1.4×	109 1.0×	212 1.9×	47 0.6×	46 1.0×	12	552
Sally Drew United States	6	253 0.8×	76 0.7×	89 0.8×	153 1.9×	31 0.7×	10	441
Songmei Huang South Korea	10	320 1.0×	106 0.9×	185 1.7×	80 1.0×	21 0.5×	12	470
Verónica Calvo United States	9	265 0.8×	167 1.5×	218 2.0×	98 1.2×	44 1.0×	13	513
Tatiana Y. Prudnikova Russia	13	267 0.8×	78 0.7×	97 0.9×	149 1.8×	24 0.5×	21	404
Francesca Miccichè Italy	9	279 0.8×	112 1.0×	147 1.3×	43 0.5×	21 0.5×	9	360

Countries citing papers authored by Xiaomei Sui

Since Specialization

Citations

This map shows the geographic impact of Xiaomei Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaomei Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaomei Sui more than expected).

Fields of papers citing papers by Xiaomei Sui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaomei Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaomei Sui. The network helps show where Xiaomei Sui may publish in the future.

Co-authorship network of co-authors of Xiaomei Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaomei Sui. A scholar is included among the top collaborators of Xiaomei Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaomei Sui. Xiaomei Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Wenwen, Qingwei Li, Jia Yu, et al.. (2025). GATA6 inhibits the periodontitis progression through regulating the Notch signaling pathway. Odontology.

Sui, Xiaomei, et al.. (2024). Serum LINC01133 combined with CEA and CA19-9 contributes to the diagnosis and survival prognosis of gastric cancer. Medicine. 103(46). e40564–e40564. 2 indexed citations

Sui, Xiaomei. (2024). Uneven Firm Growth in a Globalized World. SSRN Electronic Journal. 1 indexed citations

Wang, Yonghui, et al.. (2023). A giant breast malignant solitary fibrous tumor: A rare case report and brief review. Oncology Letters. 25(6). 249–249. 4 indexed citations

Wang, Jinxiang, et al.. (2022). The LINC00313/miR-4429 axis provides novel biomarkers for the diagnosis and prognosis of non-small cell lung cancer. Acta Biochimica Polonica. 69(2). 343–348. 6 indexed citations

Sui, Xiaomei. (2021). Financial Development, Firm Growth, and Aggregate Productivity Divergence in Europe. SSRN Electronic Journal. 2 indexed citations

Liu, Meijuan, Pengwei Wang, Xiaomei Sui, et al.. (2020). Circular RNA circABCC4 regulates lung adenocarcinoma progression via miR‐3186‐3p/TNRC6B axis. Journal of Cellular Biochemistry. 121(10). 4226–4238. 17 indexed citations

Zhang, Qifu, et al.. (2019). MicroRNA‑761 inhibits the metastasis of gastric cancer by negatively regulating Ras and Rab interactor 1. Oncology Letters. 18(3). 3097–3103. 7 indexed citations

Wang, Yonghui, et al.. (2017). Hsa-miR-599 suppresses the migration and invasion by targeting BRD4 in breast cancer. Oncology Letters. 14(3). 3455–3462. 24 indexed citations

10.

Wang, Yonghui, Xiaomei Sui, Kai Yan, et al.. (2015). BRD4 induces cell migration and invasion in HCC cells through MMP-2 and MMP-9 activation mediated by the Sonic hedgehog signaling pathway. Oncology Letters. 10(4). 2227–2232. 57 indexed citations

11.

Liu, Jin, et al.. (2015). Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma. Oncology Letters. 10(4). 1979–1984. 20 indexed citations

12.

Ji, Xuening, Fang Yang, Xiaomei Sui, et al.. (2012). Effect of fractionated irradiation on the expression of multidrug resistance genes in the CNE1 human nasopharyngeal carcinoma cell line. Molecular Medicine Reports. 7(1). 187–194. 8 indexed citations

13.

Jedlicka, Paul, Xiaomei Sui, & Arthur Gutierrez‐Hartmann. (2009). The Ets dominant repressor En/Erm enhances intestinal epithelial tumorigenesis in ApcMin mice. BMC Cancer. 9(1). 197–197. 5 indexed citations

14.

Jedlicka, Paul, Xiaomei Sui, Lori Sussel, & Arthur Gutierrez‐Hartmann. (2009). Ets Transcription Factors Control Epithelial Maturation and Transit and Crypt-Villus Morphogenesis in the Mammalian Intestine. American Journal Of Pathology. 174(4). 1280–1290. 11 indexed citations

15.

Sui, Xiaomei, et al.. (2008). Hdm2 is regulated by K-Ras and mediates p53-independent functions in pancreatic cancer cells. Oncogene. 28(5). 709–720. 19 indexed citations

16.

O’Leary, Heather, et al.. (2006). Nuclear targeting of the CaMKII anchoring protein αKAP is regulated by alternative splicing and protein kinases. Brain Research. 1086(1). 17–26. 7 indexed citations

17.

Eder, Astrid, Xiaomei Sui, Daniel Rosen, et al.. (2005). Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer. Proceedings of the National Academy of Sciences. 102(35). 12519–12524. 188 indexed citations

18.

Bramlett, Kelli, et al.. (2001). Repression of androgen-regulated gene expression by dominant negative androgen receptors. Molecular and Cellular Endocrinology. 183(1-2). 19–28. 13 indexed citations

19.

Phan, Dillon, Xiaomei Sui, Dung‐Tsa Chen, et al.. (2001). Androgen regulation of the cell–cell adhesion molecule-1 (Ceacam1) gene. Molecular and Cellular Endocrinology. 184(1-2). 115–123. 12 indexed citations

20.

Sui, Xiaomei, et al.. (1999). Specific Androgen Receptor Activation by an Artificial Coactivator. Journal of Biological Chemistry. 274(14). 9449–9454. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact